WNT3A and type 2 diabetes mellitus: Such findings reveal that the Wnt3a/β-catenin pathway is a significant factor in T2DM inhibiting bone formation by decreasing OB differentiation and osteogenic capacity, and also reveal the success of the T2DM mice model in the present study.